Submitted by Anonymous (not verified) on 13 November 2026 - 14:05
Human medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation: 09/12/2022, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation: 09/12/2022, Revision: 6, Status: Authorised